| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 36.575 | 37.663 | 44.912 | 34.960 | 15.991 | 27.523 | 37.980 | 40.028 | 38.498 |
| Total Income - EUR | - | 36.606 | 37.701 | 45.106 | 35.142 | 16.060 | 27.523 | 37.980 | 40.117 | 38.498 |
| Total Expenses - EUR | - | 5.237 | 5.324 | 8.150 | 6.368 | 7.559 | 6.049 | 7.812 | 22.223 | 19.820 |
| Gross Profit/Loss - EUR | - | 31.369 | 32.377 | 36.957 | 28.774 | 8.501 | 21.474 | 30.168 | 17.894 | 18.678 |
| Net Profit/Loss - EUR | - | 30.271 | 31.246 | 35.604 | 27.719 | 8.062 | 20.747 | 29.259 | 17.553 | 17.546 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Calmopain Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 548 | 342 | 144 | 673 | 1.088 | 1.069 | 439 | 112 | 0 |
| Current Assets | - | 30.012 | 38.136 | 35.935 | 60.175 | 8.442 | 27.824 | 46.318 | 33.584 | 20.249 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.726 | 4.203 | 3.152 | 2.508 | 0 | 2.830 | 24.183 | 4.094 | 13.369 |
| Cash | - | 28.286 | 33.932 | 32.783 | 57.668 | 8.442 | 24.994 | 22.134 | 29.490 | 6.880 |
| Shareholders Funds | - | 30.316 | 38.063 | 35.738 | 60.553 | 8.207 | 28.772 | 29.309 | 20.338 | 17.597 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 277 | 415 | 341 | 295 | 1.324 | 122 | 17.448 | 13.358 | 2.651 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Calmopain Srl